10-K Filing

COMMUNITY HEALTH SYSTEMS INC CIK: 1108109 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001564590-22-005570`
Period End Date	20211231
Filing Date	20220217
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	cyh-10k_20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 71 Cash Flow Statement 117 Stockholders Equity 36 Comprehensive Income 28

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.22B	USD	Point-in-time
Accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.12B	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.68B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$507.00M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Patient accounts receivable	`AccountsReceivableNetCurrent`	$1.93B	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Patient accounts receivable	`AccountsReceivableNetCurrent`	$2.06B	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Supplies	`Supplies`	$355.00M	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Supplies	`Supplies`	$335.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Prepaid income taxes	`PrepaidTaxes`	$50.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Prepaid income taxes	`PrepaidTaxes`	$94.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	129.61M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	132.15M	shares	Point-in-time
Prepaid expenses and taxes	`PrepaidExpensesAndTaxes`	$184.00M	USD	Point-in-time
Prepaid expenses and taxes	`PrepaidExpensesAndTaxes`	$192.00M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	129.61M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$269.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$338.00M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	132.15M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.48B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.51B	USD	Point-in-time
Land and improvements	`LandAndLandImprovements`	$534.00M	USD	Point-in-time
Land and improvements	`LandAndLandImprovements`	$515.00M	USD	Point-in-time
Buildings and improvements	`BuildingsAndImprovementsGross`	$6.05B	USD	Point-in-time
Buildings and improvements	`BuildingsAndImprovementsGross`	$5.75B	USD	Point-in-time
Equipment and fixtures	`FixturesAndEquipmentGross`	$3.09B	USD	Point-in-time
Equipment and fixtures	`FixturesAndEquipmentGross`	$3.17B	USD	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentGross`	$9.35B	USD	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentGross`	$9.76B	USD	Point-in-time
Less accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.03B	USD	Point-in-time
Less accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.20B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.55B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.32B	USD	Point-in-time
Goodwill	`Goodwill`	$4.33B	USD	Point-in-time
Goodwill	`Goodwill`	$4.22B	USD	Point-in-time
Goodwill	`Goodwill`	$4.22B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$53.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$59.00M	USD	Point-in-time
Other assets, net of accumulated amortization of $1,216 and $1,118 at December 31, 2021 and 2020, respectively	`OtherAssetsNoncurrent`	$1.91B	USD	Point-in-time
Other assets, net of accumulated amortization of $1,216 and $1,118 at December 31, 2021 and 2020, respectively	`OtherAssetsNoncurrent`	$1.90B	USD	Point-in-time
Total assets	`Assets`	$15.22B	USD	Point-in-time
Total assets	`Assets`	$16.01B	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$123.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$31.00M	USD	Point-in-time
Current operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$142.00M	USD	Point-in-time
Current operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$147.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$783.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$830.00M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$637.00M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$655.00M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$150.00M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$225.00M	USD	Point-in-time
Other	`OtherAccruedLiabilitiesCurrent`	$980.00M	USD	Point-in-time
Other	`OtherAccruedLiabilitiesCurrent`	$476.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.36B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.81B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$12.09B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$12.11B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$192.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$29.00M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$524.00M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$535.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.60B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$827.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$16.03B	USD	Point-in-time
Total liabilities	`Liabilities`	$17.06B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityFairValue`	$480.00M	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityFairValue`	$484.00M	USD	Point-in-time
Commitments and contingencies (Note 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.01 par value per share, 300,000,000 shares authorized; 132,146,282 shares issued and outstanding at December 31, 2021, and 129,612,117 shares issued and outstanding at December 31, 2020	`CommonStockValue`	$1.00M	USD	Point-in-time
Common stock, $.01 par value per share, 300,000,000 shares authorized; 132,146,282 shares issued and outstanding at December 31, 2021, and 129,612,117 shares issued and outstanding at December 31, 2020	`CommonStockValue`	$1.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.12B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.09B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-13.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-14.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-9.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.71B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.48B	USD	Point-in-time
Total Community Health Systems, Inc. stockholders deficit	`StockholdersEquity`	$-1.37B	USD	Point-in-time
Total Community Health Systems, Inc. stockholders deficit	`StockholdersEquity`	$-1.62B	USD	Point-in-time
Noncontrolling interests in equity of consolidated subsidiaries	`MinorityInterest`	$82.00M	USD	Point-in-time
Noncontrolling interests in equity of consolidated subsidiaries	`MinorityInterest`	$87.00M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.29B	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.14B	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.46B	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.54B	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$16.01B	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$15.22B	USD	Point-in-time

Income Statement 71 line items

Line Item	Tag	Value	Unit	Period
Net operating revenues	`Revenues`	$13.21B	USD	Annual
Interest income	`InvestmentIncomeInterest`	$3.00M	USD	Annual
Net operating revenues	`Revenues`	$11.79B	USD	Annual
Interest income	`InvestmentIncomeInterest`	$3.00M	USD	Annual
Net operating revenues	`Revenues`	$12.37B	USD	Annual
Interest income	`InvestmentIncomeInterest`	$3.00M	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$5.95B	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$5.41B	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$5.24B	USD	Annual
Supplies	`CostOfGoodsAndServicesSold`	$2.15B	USD	Annual
Supplies	`CostOfGoodsAndServicesSold`	$2.04B	USD	Annual
Supplies	`CostOfGoodsAndServicesSold`	$1.96B	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$2.96B	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$3.30B	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$2.96B	USD	Annual
Government and other legal settlements and related costs	`GainLossRelatedToLitigationSettlement`	$-93.00M	USD	Annual
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$1.00M	USD	Annual
Lease cost and rent	`OperatingLeaseExpense`	$321.00M	USD	Annual
Lease cost and rent	`OperatingLeaseExpense`	$308.00M	USD	Annual
Lease cost and rent	`OperatingLeaseExpense`	$327.00M	USD	Annual
Pandemic relief funds	`PandemicReliefFunds`	$148.00M	USD	Annual
Pandemic relief funds	`PandemicReliefFunds`	$601.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$540.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$608.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$558.00M	USD	Annual
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$138.00M	USD	Annual
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$48.00M	USD	Annual
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$24.00M	USD	Annual
Total operating costs and expenses	`CostsAndExpenses`	$12.56B	USD	Annual
Total operating costs and expenses	`CostsAndExpenses`	$10.66B	USD	Annual
Total operating costs and expenses	`CostsAndExpenses`	$10.97B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$650.00M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$1.40B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$1.13B	USD	Annual
Interest expense, net of interest income of $3 in 2021, 2020 and 2019	`InterestIncomeExpenseNonoperatingNet`	$-1.04B	USD	Annual
Interest expense, net of interest income of $3 in 2021, 2020 and 2019	`InterestIncomeExpenseNonoperatingNet`	$-885.00M	USD	Annual
Interest expense, net of interest income of $3 in 2021, 2020 and 2019	`InterestIncomeExpenseNonoperatingNet`	$-1.03B	USD	Annual
Loss (gain) from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$317.00M	USD	Annual
Loss (gain) from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Annual
Loss (gain) from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-54.00M	USD	Annual
Gain on sale of equity interests in Macon Healthcare, LLC	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$39.00M	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$15.00M	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$22.00M	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$10.00M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-430.00M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$499.00M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$422.00M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-185.00M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$160.00M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$131.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$-590.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$368.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$607.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$85.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$138.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$96.00M	USD	Annual
Net income (loss) attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$230.00M	USD	Annual
Net income (loss) attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-675.00M	USD	Annual
Net income (loss) attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$511.00M	USD	Annual
Basic	`EarningsPerShareBasic`	$1.82	USD	Annual
Basic	`EarningsPerShareBasic`	$4.43	USD	Annual
Basic	`EarningsPerShareBasic`	$-5.93	USD	Annual
Diluted	`EarningsPerShareDiluted`	$4.39	USD	Annual
Diluted	`EarningsPerShareDiluted`	$1.76	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-5.93	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	115.49M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	113.74M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	126.75M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	113.74M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	116.54M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	130.60M	shares	Annual

Cash Flow Statement 117 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-590.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$368.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$607.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$540.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$608.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$558.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$203.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-187.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$170.00M	USD	Annual
Government and other legal settlements and related costs	`LossContingencyAccrualProvisionNonCash`	$51.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$25.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$13.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$10.00M	USD	Annual
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$138.00M	USD	Annual
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$48.00M	USD	Annual
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$24.00M	USD	Annual
Loss (gain) from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$317.00M	USD	Annual
Loss (gain) from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Annual
Loss (gain) from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-54.00M	USD	Annual
Gain on sale of equity interests in Macon Healthcare, LLC	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$39.00M	USD	Annual
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$-131.00M	USD	Annual
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$-78.00M	USD	Annual
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$-182.00M	USD	Annual
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-93.00M	USD	Annual
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-309.00M	USD	Annual
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$136.00M	USD	Annual
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$-38.00M	USD	Annual
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$-1.00M	USD	Annual
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$15.00M	USD	Annual
Medicare accelerated payments	`IncreaseDecreaseInMedicareAcceleratedPayments`	$1.16B	USD	Annual
Repayment/derecognition of Medicare accelerated payments	`RepaymentDerecognitionOfMedicareAcceleratedPayments`	$1.08B	USD	Annual
Repayment/derecognition of Medicare accelerated payments	`RepaymentDerecognitionOfMedicareAcceleratedPayments`	$77.00M	USD	Annual
Pandemic relief funds	`IncreaseDecreaseInPandemicReliefFunds`	$104.00M	USD	Annual
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$-67.00M	USD	Annual
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$-157.00M	USD	Annual
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$16.00M	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$245.00M	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$176.00M	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$87.00M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$385.00M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-131.00M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.18B	USD	Annual
Acquisitions of facilities and other related businesses	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.00M	USD	Annual
Acquisitions of facilities and other related businesses	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.00M	USD	Annual
Acquisitions of facilities and other related businesses	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$13.00M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$438.00M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$440.00M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$469.00M	USD	Annual
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$648.00M	USD	Annual
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$17.00M	USD	Annual
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$604.00M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$10.00M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$3.00M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$4.00M	USD	Annual
Purchases of available-for-sale debt securities and equity securities	`PaymentsToAcquireInvestments`	$80.00M	USD	Annual
Purchases of available-for-sale debt securities and equity securities	`PaymentsToAcquireInvestments`	$171.00M	USD	Annual
Purchases of available-for-sale debt securities and equity securities	`PaymentsToAcquireInvestments`	$178.00M	USD	Annual
Proceeds from sales of available-for-sale debt securities and equity securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$194.00M	USD	Annual
Proceeds from sales of available-for-sale debt securities and equity securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$102.00M	USD	Annual
Proceeds from sales of available-for-sale debt securities and equity securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$92.00M	USD	Annual
Purchases of investments in unconsolidated affiliates	`PaymentsToAcquireEquityMethodInvestments`	$7.00M	USD	Annual
Purchases of investments in unconsolidated affiliates	`PaymentsToAcquireEquityMethodInvestments`	$1.00M	USD	Annual
Purchases of investments in unconsolidated affiliates	`PaymentsToAcquireEquityMethodInvestments`	$14.00M	USD	Annual
Proceeds from sale of equity interests in Macon Healthcare, LLC	`ProceedsFromSaleOfEquityMethodInvestments`	$110.00M	USD	Annual
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$156.00M	USD	Annual
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$49.00M	USD	Annual
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$113.00M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.00M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-524.00M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$177.00M	USD	Annual
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.00M	USD	Annual
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.00M	USD	Annual
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.00M	USD	Annual
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$46.00M	USD	Annual
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$156.00M	USD	Annual
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$313.00M	USD	Annual
Proceeds from noncontrolling investors in joint ventures	`ProceedsFromMinorityShareholders`	$15.00M	USD	Annual
Proceeds from noncontrolling investors in joint ventures	`ProceedsFromMinorityShareholders`	$10.00M	USD	Annual
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$19.00M	USD	Annual
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$1.00M	USD	Annual
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$11.00M	USD	Annual
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$121.00M	USD	Annual
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$116.00M	USD	Annual
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$99.00M	USD	Annual
Proceeds from sale-lease back	`ProceedsFromSaleLeaseBackTransactionFinancingActivities`	$2.00M	USD	Annual
Proceeds from sale-lease back	`ProceedsFromSaleLeaseBackTransactionFinancingActivities`	$60.00M	USD	Annual
Other borrowings	`ProceedsFromIssuanceOfOtherLongTermDebt`	$37.00M	USD	Annual
Other borrowings	`ProceedsFromIssuanceOfOtherLongTermDebt`	$53.00M	USD	Annual
Other borrowings	`ProceedsFromIssuanceOfOtherLongTermDebt`	$60.00M	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfSubordinatedLongTermDebt`	$3.04B	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfSubordinatedLongTermDebt`	$4.31B	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfSubordinatedLongTermDebt`	$4.26B	USD	Annual
Proceeds from ABL Facility	`ProceedsFromAccountsReceivableSecuritization`	$202.00M	USD	Annual
Proceeds from ABL Facility	`ProceedsFromAccountsReceivableSecuritization`	$540.00M	USD	Annual
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$3.56B	USD	Annual
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$5.49B	USD	Annual
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$4.43B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-895.00M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-514.00M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-363.00M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.46B	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$20.00M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.17B	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.68B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$216.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$507.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$196.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.68B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$216.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$507.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$196.00M	USD	Point-in-time
Interest payments	`InterestPaidNet`	$1.04B	USD	Annual
Interest payments	`InterestPaidNet`	$1.01B	USD	Annual
Interest payments	`InterestPaidNet`	$778.00M	USD	Annual
Income tax (payments) refunds, net	`IncomeTaxesPaidNet`	$-2.00M	USD	Annual
Income tax (payments) refunds, net	`IncomeTaxesPaidNet`	$-4.00M	USD	Annual
Income tax (payments) refunds, net	`IncomeTaxesPaidNet`	$3.00M	USD	Annual

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.29B	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.14B	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.46B	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.54B	USD	Point-in-time
Redeemable Noncontrolling Interests, beginning balance	`RedeemableNoncontrollingInterestEquityFairValue`	$480.00M	USD	Point-in-time
Redeemable Noncontrolling Interests, beginning balance	`RedeemableNoncontrollingInterestEquityFairValue`	$484.00M	USD	Point-in-time
Comprehensive income (loss)	`ComprehensiveIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterests`	$266.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterests`	$-641.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterests`	$545.00M	USD	Annual
Contributions from noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$7.00M	USD	Annual
Contributions from noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$15.00M	USD	Annual
Distributions to noncontrolling interests	`DistributionsToNoncontrollingInterestsNetOfContributions`	$-31.00M	USD	Annual
Distributions to noncontrolling interests	`DistributionsToNoncontrollingInterestsNetOfContributions`	$-34.00M	USD	Annual
Distributions to noncontrolling interests	`DistributionsToNoncontrollingInterestsNetOfContributions`	$-39.00M	USD	Annual
Purchase of subsidiary shares from noncontrolling interests	`MinorityInterestDecreaseFromRedemptions`	$3.00M	USD	Annual
Purchase of subsidiary shares from noncontrolling interests	`MinorityInterestDecreaseFromRedemptions`	$-3.00M	USD	Annual
Purchase of subsidiary shares from noncontrolling interests	`MinorityInterestDecreaseFromRedemptions`	$13.00M	USD	Annual
Other reclassifications of noncontrolling interests	`OtherReclassificationsOfNoncontrollingInterests`	$-9.00M	USD	Annual
Other reclassifications of noncontrolling interests	`OtherReclassificationsOfNoncontrollingInterests`	$1.00M	USD	Annual
Other reclassifications of noncontrolling interests	`OtherReclassificationsOfNoncontrollingInterests`	$2.00M	USD	Annual
Adjustment to redemption value of redeemable noncontrolling interests	`RedeemableNoncontrollingInterestsChangeInRedemptionValue`	$-15.00M	USD	Annual
Adjustment to redemption value of redeemable noncontrolling interests	`RedeemableNoncontrollingInterestsChangeInRedemptionValue`	$-13.00M	USD	Annual
Adjustment to redemption value of redeemable noncontrolling interests	`RedeemableNoncontrollingInterestsChangeInRedemptionValue`	$-21.00M	USD	Annual
Cancellation of restricted stock for tax withholdings on vested shares	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-5.00M	USD	Annual
Cancellation of restricted stock for tax withholdings on vested shares	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-1.00M	USD	Annual
Cancellation of restricted stock for tax withholdings on vested shares	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-1.00M	USD	Annual
Section 3(a)(9) exchange	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$86.00M	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$13.00M	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$25.00M	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$10.00M	USD	Annual
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.29B	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.14B	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.46B	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.54B	USD	Point-in-time
Redeemable Noncontrolling Interests, ending balance	`RedeemableNoncontrollingInterestEquityFairValue`	$480.00M	USD	Point-in-time
Redeemable Noncontrolling Interests, ending balance	`RedeemableNoncontrollingInterestEquityFairValue`	$484.00M	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-590.00M	USD	Annual
Net change in fair value of interest rate swaps, tax	`OtherComprehensiveIncomeLossNetChangeInFairValueInterestRateSwapsTax`	$1.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$368.00M	USD	Annual
Net change in fair value of interest rate swaps, tax	`OtherComprehensiveIncomeLossNetChangeInFairValueInterestRateSwapsTax`	-	USD	Annual
Net change in fair value of interest rate swaps, tax	`OtherComprehensiveIncomeLossNetChangeInFairValueInterestRateSwapsTax`	-	USD	Annual
Net income (loss)	`ProfitLoss`	$607.00M	USD	Annual
Amortization and recognition of unrecognized pension cost components, tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$2.00M	USD	Annual
Amortization and recognition of unrecognized pension cost components, tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	-	USD	Annual
Amortization and recognition of unrecognized pension cost components, tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	-	USD	Annual
Net change in fair value of interest rate swaps, net of tax of $0 for the years ended December 31, 2021 and 2020 and $1 for the year ended December 31, 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	Annual
Net change in fair value of interest rate swaps, net of tax of $0 for the years ended December 31, 2021 and 2020 and $1 for the year ended December 31, 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-1.00M	USD	Annual
Net change in fair value of available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$4.00M	USD	Annual
Net change in fair value of available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$4.00M	USD	Annual
Net change in fair value of available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-5.00M	USD	Annual
Amortization and recognition of unrecognized pension cost components, net of tax of $0, $2 and $0 for the years ended December 31, 2021, 2020 and 2019, respectively	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-3.00M	USD	Annual
Amortization and recognition of unrecognized pension cost components, net of tax of $0, $2 and $0 for the years ended December 31, 2021, 2020 and 2019, respectively	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$7.00M	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-4.00M	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-2.00M	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$1.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-589.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$366.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$603.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$138.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$96.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$85.00M	USD	Annual
Comprehensive income (loss) attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$228.00M	USD	Annual
Comprehensive income (loss) attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$507.00M	USD	Annual
Comprehensive income (loss) attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-674.00M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.